Background: Endothelial-to-mesenchymal transition (EndMT) is implicated in the development of organ fibrosis. Results: Loss of the autophagy gene ATG7 promotes EndMT and up-regulates TGF␤ signaling and the associated pro-fibrotic genes. Endothelial-specific ATG7 knock-out mice exhibited increased bleomycin-induced pulmonary fibrosis. Conclusion: ATG7 is a novel regulator of EndMT-induced organ fibrosis. Significance: Intact endothelial autophagy prevents aberrant EndMT and represents a potential target to limit organ fibrosis.
Pulmonary fibrosis is a progressive disease characterized by fibroblast proliferation and excess deposition of collagen and other extracellular matrix components. Although the origin of fibroblasts is multifactorial, recent data implicate endothelialto-mesenchymal transition as an important source of fibroblasts. We report herein that loss of the essential autophagy gene ATG7 in endothelial cells (ECs) leads to impaired autophagic flux accompanied by marked changes in EC architecture, loss of endothelial, and gain of mesenchymal markers consistent with endothelial-to-mesenchymal transition. Loss of ATG7 also up-regulates TGF␤ signaling and key pro-fibrotic genes in vitro. In vivo, EC-specific ATG7 knock-out mice exhibit a basal reduction in endothelial-specific markers and demonstrate an increased susceptibility to bleomycin-induced pulmonary fibrosis and collagen accumulation. Our findings help define the role of endothelial autophagy as a potential therapeutic target to limit organ fibrosis, a condition for which presently there are no effective available treatments.
The endothelium is composed of a monolayer of endothelial cells (ECs) 2 that line the lumen of all blood vessels. It provides a protective barrier between all tissues and the circulating blood and functions as a selective sieve to facilitate bidirectional passage of macromolecules and gases that facilitates vascular homeostasis (1, 2) . ECs, however, serve additional roles among which is the transition of ECs into mesenchymal cells (3) . This form of EC plasticity is called EndMT (3) . EndMT is characterized by acquisition of the mesenchymal or myofibroblastic phenotype that can be detected by positive staining using various mesenchymal markers including ␣ smooth muscle actin (␣SMA), neural cadherin (N-cadherin), and types I and III collagen with complementary loss of endothelial markers such as CD31 and vascular-endothelial cadherin (VE-cadherin) (4) . In addition to the adoption of an activated, pro-fibrogenic phenotype, ECs undergoing EndMT also lose their cell-cell junctions and gain migratory and invasive capacity (4) . EndMT is recognized as a crucial component of normal heart development, endocardial cushion formation (5, 6) , and wound healing (7) . It has of late also been implicated in a wide variety of pathological conditions including cancer and organ fibrosis (8, 9) . The etiologic factors that initiate fibrotic disorders are quite diverse and in most cases remain obscure. Accumulation of activated myofibroblasts in the affected tissues remains a critical element in the evolution of such diseases as well as a potential therapeutic target (4) . Fibroblasts have myriad origins, although recent data suggest that EndMT, similar to epithelial-to-mesenchymal transformation, may be a quantitatively important element of this process (10) . Microscopy and EC-lineage analyses conducted in animal models of tissue fibrosis support EndMT as an important source of tissue myofibroblasts in various organs (11) (12) (13) (14) . For instance, Hashimoto et al. reported that 16% of the lung fibroblasts from bleomycin (BLM)-treated mice (a surrogate model for pulmonary fibrosis) were of EC origin versus 3% of those from saline-treated mice (13) . Mechanistically, it is generally accepted that TGF␤ signaling plays a crucial role in tissue fibrosis (15) (16) (17) as well as in the generation of myofibroblasts through EndMT (3, 12, 18, 19) . In eukaryotic cells, autophagy is a highly conserved and tightly regulated cellular process involved in the turnover of cytoplasmic organelles and proteins through a lysosome-dependent degradation process (20 -23) . Initially described as an alternative cell death pathway, accumulating evidence suggests that autophagy is an adaptive response aimed at promoting cell survival and limiting cell death after exposure to stressful stimuli (20 -24) . The molecular signaling pathways regulating autophagy are complex, and readers are directed to several comprehensive articles on the topic (20 -23, 25, 26) . Briefly, autophagosome formation, a critical step in autophagy, is dependent on a catalytic step mediated by ATG7, which exhibits homology to the E1 ubiquitin activating enzymes (27) . ATG7 whole body knock-out mice die within 24 h of birth (28) , and conditional deletion of ATG7 in an array of tissues leads to marked alterations in tissue hemostasis, with accumulation of damaged proteins and organelles (29 -31) . Emerging data support autophagic induction as a critical response of normal and cancer cells to environmental changes. In cancer cells, autophagy also regulates epithelial-to-mesenchymal transformation and cell invasion in a TGF␤-dependent manner (32) .
In the present study we hypothesized that preserved autophagic flux is important for the prevention of aberrant EndMT and organ fibrosis. We demonstrate that knockdown of ATG7 promotes EndMT in vitro and up-regulates key genes involved in TGF␤ signaling and fibrosis. In mice, EC-specific knock-out of ATG7 led to an increase in BLM-induced pulmonary fibrosis. These data suggest that autophagy may be an important and novel pathway linking EndMT to organ fibrosis.
EXPERIMENTAL PROCEDURES
Cell Culture, RNA Interference, and Actinomycin D Treatment-Human umbilical vein ECs (HUVECs, Lonza) and human pulmonary aortic ECs (HPAECs, Lonza) were grown in EC growth medium-2 (EGM TM -2 Bulletkit TM ; Lonza) containing growth factors, serum, and antibiotics. siRNA-mediated ATG7 and ATG5 gene knockdown studies were performed with siATG7, siATG5, or scrambled control (Ambion) and the Dharmafect-4 transfection reagent (Dharmacon) in accordance with the manufacturer's guidelines. For analysis of mRNA stability, HUVECs were transfected with siATG7 or scrambled control for 24 h followed by the addition of 5 M actinomycin D (Sigma), and the cells were harvested at the indicated time points.
Quantitative Real Time PCR and PCR Array-Total RNA was extracted with Trizol reagent (Invitrogen) and precipitated with isopropyl alcohol. Complementary DNA (cDNA) was synthesized with the Quantitect kit (Qiagen) and subjected to quantitative RNA PCR with the StepOnePlus TM Real-Time PCR System (Applied Biosystems). Briefly, SYBR Select Master Mix or TaqMan Gene Expression Assays (both Applied Biosystems) were mixed with forward and reverse primers for ATG7, CD31, VE-cadherin, Tie2, ␣SMA, N-cadherin, fibroblast-specific protein-1 (FSP1), Slug, TGF␤1, TGFBR1, TGFBR2, collagen I, connective tissue growth factor (CTGF), ␤-actin, and GAPDH (Table 1) according to the manufacturer's instructions. Quantitative real-time PCR analysis of 84 TGF␤-related genes was performed with the human TGF␤/BMP signaling pathway RT 2 profiler PCR array (PAHS-035, Qiagen). Data were analyzed with the manufacturer's integrated webbased software package.
Immunoblot and Immunofluorescence-Lysates from ECs were prepared in radioimmune precipitation assay (RIPA) buffer (Sigma) 24, 48, and 72 h post-transfection with either siATG7 or its scrambled control. Total protein was isolated from mouse lungs in RIPA buffer. Equal amounts of protein were loaded on SDS-polyacrylamide gels and processed for immunoblot analysis with antibodies specifically directed at the following proteins: ATG7 (Cell Signaling #2631), p62 (Cell Signaling #5114), LC3 (Cell Signaling #4108), CD31 (Cell Signaling #3528), VE-cadherin (Santa Cruz Biotechnology #6458), Tie2 (Santa Cruz Biotechnology 
Genes

Nucleotide sequences
Hs-ATG7 forward 5Ј-ATTGCTGCATCAAGAAACCC-3Ј Hs-ATG7 reverse 5Ј-GATGGAGAGCTCCTCAGCA-3Ј Hs-CD31 forward 5Ј-CCTTCTGCTCTGTTCAAGCC-3Ј Hs-CD31 reverse 5Ј-GGGTCAGGTTCTTCCCATTT-3Ј Hs-VE-cadherin forward 5Ј-ACAGAGCTCCACTCACGCTC-3Ј Hs-VE-cadherin reverse 5Ј-CATGAGCCTCTGCATCTTCC-3Ј Hs-Slug forward 5Ј-TCGGACCCACACATTACCTT-3Ј Hs-Slug reverse 5Ј-GCAGTGAGGGCAAGAAAAAG-3Ј Hs-N-cadherin forward 5Ј-GTGCATGAAGGACAGCCTCT-3Ј Hs-N-cadherin reverse 5Ј-CCACCTTAAAATCTGCAGGC-3Ј Hs-FSP1 forward 5Ј-AACTAAAGGAGCTGCTGACCC-3Ј Hs-FSP1 reverse 5Ј-TGTTGCTGTCCAAGTTGCTC-3Ј Hs-CTGF forward 5Ј-CAGGCTAGAGAAGCAGAGCC-3Ј Hs-CTGF reverse 5Ј-TGGAGATTTTGGGAGTACGG-3Ј Hs-TGFBR1 forward 5Ј-GCTGCTCCTCCTCGTGCT-3Ј Hs-TGFBR1 reverse 5Ј-TTGTCTTTTGTACAGAGGTGGC-3Ј Hs-TGFBR2 forward 5Ј-CTGCACATCGTCCTGTGG-3Ј Hs-TGFBR2 reverse 5Ј-GGAAACTTGACTGCACCGTT-3 Hs-TGF␤1 forward 5Ј-CCCTGGACACCAACTATTGC-3Ј Hs-TGF␤1 reverse 5Ј-CTTCCAGCCGAGGTCCTT-3 Hs-Tie2 forward 5Ј-GGAGTCAGCTTGCTCCTTTC-3Ј Hs-Tie2 reverse 5Ј-AGGCAATGCAGGTGAGAGAT-3 Hs-collagen I forward 5Ј-AAGAGGAAGGCCAAGTCGAG-3Ј Hs-collagen I reverse
#MAB374). After incubation with the appropriate horseradish peroxidase-associated secondary antibodies (Santa Cruz Biotechnology), bands were visualized with an enhanced chemiluminescence detection system (Amersham Biosciences) and their intensities quantified by densitometry using ImageJ software.
Immunofluorescence signals from ATG7, CD31, Tie2, ␣SMA, and ␣-actinin staining were visualized with standard protocols 72 h post-transfection.
Generation of Endothelial Cell-specific ATG7 Knock-out Mice-Floxed ATG7 mice (ATG7 flox/flox mice) were crossed with VE-cadherin Cre transgenic mice to generate EC-specific ATG7 knock-out (EC-ATG7 Ϫ/Ϫ ) mice (33) . The characterization of these mice has been previously described (33) . All animal-related procedures described herein were reviewed and approved by the St. Michael's Hospital Animal Care Committee.
Bleomycin Instillation-A single dose of BLM (0.0015 units/g body weight, Sigma) was instilled endotracheally on day 0-to 20-week-old mice (34 -37) .
Imunohistochemistry-Lungs were perfused, harvested, and cleared of extraneous tissue before being fixed in O.C.T. compound (Tissue-Tek) for cryosectioning. Sections (4 m) were stained with CD31 (Abcam #ab28364), hematoxylin and eosin (H&E), or Masson's trichrome.
Statistical Analysis-Data are expressed as the mean Ϯ S.E. unless otherwise indicated. Student's t test was applied when the means of two groups were compared. Differences between multiple means were evaluated by analysis of variance, and when overall differences were detected, individual means were compared post-hoc with the Bonferroni's test. A p value Ͻ0.05 was considered to indicate statistical significance.
RESULTS
Loss of ATG7 Evokes Marked Morphological and Ultrastructural Changes in HUVECs-
We used siRNA technology to knock down ATG7 expression in HUVECs. Although three groups of HUVECs were studied (non-transfected, scrambled control-transfected, and siATG7-transfected), results from the non-transfected group are not presented as they were indistinguishable from those of the scrambled control-transfected group. Quantitative PCR and immunoblot analysis confirmed markedly lower ATG7 expression in HUVECs after siATG7 transfection (Fig. 1, A and B) . Autophagic flux is commonly evaluated by the concomitant assessment of p62 protein levels and the LC3-II to LC3-I ratio (38, 39) . The increase in p62 and reduction in LC3-II levels observed in ATG7-silenced cells is consistent with impaired autophagic flux (Fig. 1 , B and C) (38, 39) . Notably, ATG7-silenced HUVECs, when viewed under light microscopy, exhibited a conspicuous transition from the distinctive cobblestone-like appearance to an enlarged spindleshaped pattern that is consistent with fibroblast-like morphology (Fig. 1D ). These changes were accompanied by an elevation in ␣-actinin expression and mesenchymal cell-like cytoskeletal protein re-organization in ATG7-silenced HUVECs (Fig. 1E ) (40) .
Loss of ATG7 Promotes Endothelial-to-Mesenchymal Transition-like Phenotypic Switching in ECs-
The differential transcript and protein levels of EC markers CD31, VE-cadherin, and Tie2 and mesenchymal markers ␣SMA, N-cadherin, FSP1, and Slug in siATG7-versus scrambled control-transfected HUVECs are indicative of the loss of endothelial and gain of mesenchymal markers and are consistent with EndMT (Fig. 2,  A-C) . To verify whether the loss of ATG7-associated phenotype observed is unique to HUVECs, we conducted parallel studies with HPAECs and confirmed via real-time PCR, Western blot, and microscopic analysis that ATG7-silenced HPAECs also displayed a marked reduction in ATG7 levels (Fig. 3, A and B ) that was associated with an increase in p62 and a decrease in LC3-II expression, i.e. impaired autophagic flux (Fig. 3B) . Furthermore, loss of ATG7 expression in HPAECs coincided with changes in marker expression, morphological alterations, and TGFBR2 expression that are consistent with EndMT (Fig. 3, C-G) .
Loss of ATG7 Activates the TGF␤ Signaling Pathway in HUVECs-HUVECs lacking ATG7 had significantly higher TGF␤1 transcript and protein levels than those that had been transfected with the scrambled control (Fig. 4, A and B) . TGF␤1 binds mainly to two serine threonine kinase receptors, transforming growth factor receptor type I (TGFBR1) and type II (TGFBR2) (41) . TGFBR2 is constitutively active and binds with and phosphorylates TGFBR1 after ligand binding (41, 42) . The resultant complex goes on to phosphorylate SMAD proteins and enters the cell nucleus where it acts as a transcription factor for various TGF␤-dependent pro-fibrotic genes, such as CTGF, plasminogen activator inhibitor-1, and multiple collagens (41, (43) (44) (45) (46) . ATG7 loss in HUVECs corresponded with increased TGFBR1 and TGFBR2 transcript content and SMAD2/3 phosphorylation (Fig. 4, B-D) , suggesting a molecular link between autophagy and the TGF␤ network. TGF␤-responsive pro-fibrotic genes CTGF and collagen I were also significantly upregulated in the ATG7-silenced HUVECs in comparison to the control HUVECs (Fig. 4, E-G) .
To understand the relationship between loss of ATG7 and TGF␤ signaling in endothelial cells, we performed mRNA stability/expression assay using the transcription inhibitor actinomycin D. Our data demonstrates that loss of ATG7 in HUVECs significantly up-regulated TGF␤1, TGFBR1, and TGFBR2 at the mRNA and protein levels (Fig. 4, A-D) . However, after actinomycin D treatment, the RNA and protein expression levels of TGF␤1, TGFBR1, and TGFBR2 were diminished, indicating reduced transcription and translation (Fig. 5, A-D) . These results were in agreement with the data from scrambled control treated HUVECs (Fig. 5, A-D ). Our findings demonstrate that loss of ATG7-associated increased TGF␤ activity in HUVECs is most likely due to increased transcription of TGF␤ ligand and its cognate receptors (Fig. 5, A-D) .
We next tested whether other pharmacological or genetic inhibitors of autophagy had similar effects on EndMT. Incubation of HUVECs with bafilomycin, a known inhibitor of autophagic-flux, resulted in marked down-regulation of LC3-II and up-regulation of p62 protein levels (Fig. 6A) . Pharmacological inhibition of endothelial autophagy after bafilomycin treatment was also accompanied by significant up-regulation of the mesenchymal markers Slug, ␣SMA, and N-cadherin (Fig. 6B) . Similarly, successful knockdown of another essential autophagy gene, ATG5, also inhibited autophagy as demonstrated by decreased LC3-II and increased p62 protein levels (Fig. 6D) . Knockdown of ATG5 significantly increased transcript levels of ␣SMA and N-cadherin in HUVECs (Fig. 6E) . Additionally, loss of ATG5 or bafilomycin treatment both upregulated TGF␤1, TGFBR1, and TGFBR2 transcript levels, similar to what was observed in ATG7-silenced HUVECs (Fig. 6, C  and F) . In contrast to ATG7 knockdown of HUVECs, genetic inhibition by knockdown of ATG5 or pharmacological inhibition by bafilomycin did not show a significant effect on expression of endothelial markers; CD31, Tie2, and VE-cadherin (Fig.  6, B and E) . image of an agarose gel shows the PCR products of ATG7 and GAPDH primers derived from equal amounts of cDNA. B, ATG7 silencing was accompanied by a reduction in autophagic flux. Western blotting confirmed lower ATG7 and LC3-II levels as well as higher p62 levels in HUVECs lacking ATG7. GAPDH was used as a loading control. C, quantitative analysis indicated that siATG7 transfection significantly and time-dependently reduced the LC3-II/LC3-I ratio in HUVECs. D, scrambled control-transfected HUVECs, cultured on a two-dimensional plate, formed a confluent monolayer with the typical EC "cobblestone" morphology (left panel). ATG7 silencing resulted in marked morphological changes whereby HUVECs took on an enlarged spindle-shaped appearance with smooth surfaces (right panel). Both micrographs were taken at the same magnification. Scale bar ϭ 200 m. E, immunofluorescent micrographs demonstrating cytoskeletal protein re-organization and ATG7 expression in HUVECs after ATG7 silencing. ␣-Actinin positivity is indicated in red; ATG7 positivity is indicated in green, and nuclei were stained with DAPI (blue). Scale bar ϭ 10 m. *, p Ͻ 0.05; ***, p Ͻ 0.001 versus corresponding the scrambled control. n ϭ 3-4 in triplicate.
TGF␤-associated Slug induction is known to play an important role in TGF␤-induced EndMT (47) . In order to investigate the role of Slug in loss of ATG7-associated TGF␤ induction and EndMT, we successfully knocked down Slug using siRNA (Fig.  6, G and H) . Loss of Slug was associated with significantly increased CD31, VE-cadherin, and Tie2 expression in siSlugtransfected HUVECs in comparison to the scrambled controltransfected HUVECs (Fig. 6I) . TGF␤ treatment of the siSlugand scrambled control-transfected HUVECs significantly up-regulated mesenchymal markers, ␣SMA, N-cadherin, and FSP1, but this up-regulation was accompanied with significantly increased endothelial markers, CD31, VE-cadherin, and Tie2 (Fig. 6J) , suggesting that Slug is required to induce a complete TGF␤-mediated EndMT in endothelial cells.
Endothelial Cell-specific Loss of ATG7 Exacerbates Bleomycin-induced Pulmonary Fibrosis in Vivo-To evaluate the potential translational implications of our in vitro data and to circumvent the early lethality observed in systemic ATG7 knock-out mice (28), we generated EC-ATG7 Ϫ/Ϫ mice (48). These mice demonstrate loss of ATG7-associated impaired autophagic flux only in the ECs (33). EC-ATG7 Ϫ/Ϫ mice are born in a Mendelian ratio, and they do not present with any apparent basal phenotype (33) . Histological assessments revealed significantly less CD31 staining in lung sections from EC-ATG7 Ϫ/Ϫ mice versus WT littermate controls (Fig. 7A) , and notably, these differences were most evident in the endothelial lining of the vessel walls (Fig. 7A) . Quantitative PCR performed on the RNA isolated from the lung tissue of the WT and EC-ATG7 Ϫ/Ϫ mice demonstrated significantly reduced CD31, VE-cadherin, and Tie2 expression (Fig. 7B) . However, the basal transcript levels of mesenchymal markers, Slug, ␣SMA and N-cadherin, were similar between the groups (Fig.  7B) .
We observed profound alterations in the pulmonary microanatomy of BLM-treated EC-ATG7 Ϫ/Ϫ when compared with similarly treated WT mice. These differences included increased alveolar septal thickening and infiltration of the parenchyma by inflammatory cells with a resultant increase in pulmonary fibrosis (Fig. 7D ) and collagen content (Fig. 7D) 
days after BLM instillation in the EC-ATG7
Ϫ/Ϫ mice. Concordant with earlier reports (49, 50) , the collagen deposition and distribution pattern was primarily bronchocentric. Exacerbated pulmonary fibrosis in BLM-treated EC-ATG7 Ϫ/Ϫ mice was further associated with increased TGF␤1 expression and activity along with up-regulation of ␣SMA and TGF␤-responsive CTGF expression (Fig. 7C) .
DISCUSSION
The main observation made in this study is that loss of endothelial autophagic flux may lead to aberrant EndMT and that organ fibrosis (as assessed in the lung), a known consequence of EndMT, was increased in vivo after conditional deletion of ATG7 in EC. These data suggest that endothelial autophagy may be a potentially novel and previously unrecognized target to limit organ fibrosis, a condition for which at the present time there remains no effective therapies.
The genetic and molecular basis of autophagy was initially characterized in yeast (51) , and a number of autophagy-related genes (ATG) were subsequently identified as being essential for the formation of the autophagosome or for the subsequent fusion of the autophagosome with the lysosome (52). Because these autophagy genes are highly conserved throughout evolution, it is believed that autophagy plays a critical role in the survival of organisms. Current evidence suggests that autophagy maintains cellular homeostasis through the removal of damaged proteins and organelles and also serves as an important pro-survival mechanism for cells during stress. Autophagic flux is precisely regulated by both extracellular and intracellular cues in an effort to promote pro-survival pathways while minimizing destruction of proteins and organelles that are required for cell survival (53) . Although nutrient/amino acid deprivation is recognized as the classic stress factor inducing autophagy, it has become increasingly evident that that multiple forms of stress can trigger a rise in autophagic flux. Within the cardiovascular field, most of the work on autophagy has centered on the role this process plays in the myocardium (54, 55) . Many are now evaluating how normal and abnormal autophagy also impacts vascular pathophysiology, and there is a growing body of evidence that suggests that autophagic dysregulation may be a common pathway through which vascular aging and its associated pathologies develop (56) .
Preliminary data suggest an important role for autophagic flux in the regulation of EC homeostasis, and there is evidence that loss of autophagy may be a central mechanism through which risk factors cause endothelial dysfunction. Furthermore, autophagy may also be involved in the paracrine regulation and secretion of key endothelial effectors, such as nitric oxide and von Willebrand factor (33, 57) . The biosynthetic pathway of von Willebrand factor is complex and involves various posttranslational modifications in the endoplasmic reticulum and Golgi bodies followed by assembly into discrete structures known as Weibel-Palade bodies. A reduction in von Willebrand factor secretion was observed in mice lacking endothelial ATG5 or ATG7. Various vascular risk factors, including oxidized low density lipoprotein, hyperglycemia, shear stress, ␤-amyloid, and angiotensin-II, have been shown to impair EC function, in part through inhibiting autophagic flux (58 -60) . Although ECs are known to display a significant amount of plasticity, particularly under stressful and pathophysiological conditions, there has been no report linking endothelial autophagy to maintenance of cellular architecture, phenotypic transformation, and/or mesenchymal transition.
EndMT was first described during embryonic cardiogenesis whereby ECs give rise to mesenchymal cells that form the endocardial cushion, which in turn contributes to the development of the septa and cardiac valves. Evidence suggests that EndMT occurs in the post-natal state as well and is involved in the development of organ fibrosis, pulmonary vein stenosis, aberrant vascular remodeling, calcification (via osteoblastic and chondrocytic differentiation), and more recently cerebral cavernous malformations (18, 61-64) . The hallmark of these phenomena is usually a loss of endothelial and gain of mesenchymal HUVECs were transfected with scrambled control or siATG7. Total RNA and protein were extracted at 24, 48, and 72 h post-transfection. ATG7 knockdown elevated, in a time-dependent fashion, TGF␤1 transcript (A) and TGF␤1, TGFBRI, pSMAD2/3 and SMAD2/3 protein expressions (B). These changes were accompanied by up-regulation of TGFBR1 and TGFBR2 transcript levels (C and D), CTGF and collagen I transcript level (E and F), and protein levels (G). *, p Ͻ 0.05; **, p Ͻ 0.01; ***, p Ͻ 0.0001 versus corresponding scrambled control group. n ϭ 3 in triplicates.
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and stem-cell like markers. The TGF␤ pathway is the major inducer of EndMT, which is mediated largely through phosphorylation of SMAD proteins, that in turn regulate transcription of key target genes (12) . Understanding the biological cues that regulate EndMT can, therefore, provide important insights into the pathophysiology and potential treatment of several specific diseases in addition to the more general process of organ fibrosis.
Pulmonary fibrosis is a devastating disease for which there remains no cure. Because the accumulation of myofibroblasts is the pathologic feature of pulmonary fibrosis, research efforts to date have predominantly centered on identifying the source of fibroblasts. Although historically it was believed that fibroblasts arise from resident pulmonary mesenchymal cells, recent data suggest that a significant proportion of the fibroblast population in fact originates from epithelial-to-mesenchymal transformation and EndMT, in addition to bone marrow progenitor cells that are recruited to the injured lung (61).
Several risk factors that contribute to pulmonary fibrosis appear to overlap and potentially modulate autophagic flux. For example, advanced age is one of the key risk factors for pulmonary fibrosis. It is also well recognized that autophagy diminishes with advanced age, and it has been suggested that the resultant accumulation of damaged proteins and organelles may incite a profound ER stress response leading to cellular senescence characteristic of pulmonary fibrosis (65) . Indeed, impaired epithelial autophagy has been found in idiopathic pulmonary fibrosis; immunohistochemical evaluation of human idiopathic pulmonary fibrosis specimens revealed that epithelial cells showed increased cellular senescence, and both epithelial cells and fibroblasts in the fibroblastic foci expressed increased ubiquitinated proteins and p62 (66) . Furthermore, in in vitro models, autophagy inhibition was sufficient to induce epithelial cell senescence and myofibroblast differentiation (67) . These data argue that loss of autophagy may be a central mechanism through which pulmonary fibrosis occurs (65) . Although both epithelial to mesenchymal transformation and EndMT transition are important sources of fibroblasts, we focused our study specifically on the role of autophagy in EndMT-induced pulmonary fibrosis.
In both HUVECs and HPAECs, loss of endothelial autophagy, induced by silencing of the essential autophagy gene ATG7, promoted EndMT. Indeed, silencing of ATG7 was accompanied by marked morphological and ultra-structural changes changing cells from an initial "cobblestone-like EC morphology" to an enlarged spindle-shaped, smooth-surfaced "fibroblast-like morphology" (Figs. 1, D and E, and 3, E and F) . These morphological changes further corresponded to cytoskeletal protein re-organization, confirmed by ␣-actinin staining (Figs. 1E and 3F) . The fibroblast-like morphology was further associated with reduced expression of the endothelial markers CD31, VE-cadherin, and Tie2 and increased expression of the mesenchymal markers ␣SMA, N-cadherin, and FSP1 (Figs. 2, A-C, and 3, C and D) . VE-cadherin is processed through the endosomal-lysosomal pathway, and autophagy/ lysosomal inhibitors have been previously shown to prevent VE-cadherin degradation resulting in accumulation of VE-cadherin protein (68) . In accord with these past observations, we observed a significant reduction in VE-cadherin transcript content but accumulation of VE-cadherin protein, arguably due to impaired processing of VE-cadherin in ATG7-deficient HUVECs (Fig. 2B) . Loss of ATG7-associated accumulation of JANUARY 30, 2015 • VOLUME 290 • NUMBER 5
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VE-cadherin protein was not specific to HUVECs, as a similar accumulation was observed in ATG7-silenced HPAECs (Fig.  3D) .
Because TGF␤ signaling is the main driver of EndMT, we evaluated this signaling pathway after ATG7 silencing. We found that in ATG7-silenced HUVECs, TGF␤ signaling was up-regulated, and specifically, expression of TGF␤1 and its receptors TGFBR1 and TGFBR2 were increased. This up-regulation of TGF␤1 and its receptors was further associated with increased SMAD2/3 phosphorylation, which contributed to the observed enhanced transcription of pro-fibrotic genes (Fig.  4, A-G) . A PCR array for human TGF␤ and BMP signaling was performed to further assess the TGF␤ signaling activation. As shown in Table 2 , several TGF␤ signaling-associated genes including NOG, BMPR1B, TGF␤1, ITGB5, PDGFB, FOS, FST, COL1A1, SOX4, CDC25A, DLX2 and BMP5 were significantly up-regulated (Table 2) .
We also tested whether other pharmacological or genetic inhibitors of autophagy had a similar effect on EndMT. Incubation of HUVECs with bafilomycin, a known inhibitor of autophagic flux, resulted in marked down-regulation of LC3-II and up-regulation of p62 protein levels (Fig. 6A) . Inhibition of autophagy after bafilomycin treatment was accompanied by significant up-regulation of the mesenchymal markers, Slug, ␣SMA, and N-cadherin (Fig. 6B) . Similarly, successful knockdown of another essential autophagy gene ATG5 also inhibited autophagy as shown by decreased LC3-II and increased p62 protein levels (Fig. 6D ) and significantly up-regulated the transcript levels of ␣SMA and N-cadherin in HUVECs (Fig. 6E ). Similar to loss of ATG7 in HUVECs, pharmacological (by bafilomycin) and genetic inhibition (by loss of ATG5) both upregulated TGF␤1, TGFBR1, and TGFBR2 expression and increased mesenchymal markers (Fig. 6, C and F) . In contrast to ATG7 knockdown in HUVECs, genetic inhibition by knockdown of ATG5 or pharmacological inhibition by bafilomycin did not show a significant effect on the expression level of endothelial markers CD31, Tie2, and VE-cadherin (Fig. 6, B and E) . The basis for these differences is not entirely clear at this point, although ATG7 does have autophagy-independent functions (69).
The BLM-induced model of pulmonary fibrosis is a widely employed experimental model of organ fibrosis. To directly link endothelial autophagy with the pathobiology of pulmonary fibrosis, we treated ATG7 EC-specific conditional knock-out mice with BLM. Lungs from EC-ATG7 Ϫ/Ϫ mice demonstrated a modest but significant basal reduction in the endothelial markers CD31, VE-cadherin, and Tie2 (Fig. 7, A and B) . Twenty-one days after BLM treatment, there was greater fibrosis noted in the lungs of EC-ATG7 Ϫ/Ϫ mice compared with WT controls. Exacerbated pulmonary fibrosis in BLM-treated EC-ATG7 Ϫ/Ϫ mice was further associated with increased TGF␤1 expression and activity along with up-regulation of ␣SMA and TGF␤-responsive CTGF expression (Fig. 7C) . Collagen content is an established measure of murine pulmonary fibrosis (70) , and increased collagen content was observed in the lungs of EC-ATG7 Ϫ/Ϫ mice compared with their WT littermate controls after BLM administration (Fig. 7D) . A putative model is presented in Fig. 8 that summarizes the effect of ECspecific loss of ATG7 on EndMT and organ fibrosis.
In conclusion, we provide novel evidence to suggest that loss of in vivo endothelial autophagy exacerbates the fibrotic response in mice. We propose that this occurs through a regulatory effect of autophagy on restraining TGF␤-dependent EndMT. 
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